首页 > 最新文献

International journal of Ayurveda research最新文献

英文 中文
Role of honey (Madhu) in the management of wounds (Dushta Vrana). 蜂蜜(Madhu)在伤口管理中的作用(Dushta Vrana)。
Pub Date : 2010-10-01 DOI: 10.4103/0974-7788.76793
Tukaram S Dudhamal, S K Gupta, C Bhuyan

Application of Madhu (honey) is one among the Shashthi Upakrama (sixty treatment modalities) described by Sushruta. Clinical observation has shown its effectiveness in treatment of Dushta Vrana (chronic wounds). We report a case of Dushta Vrana on the anterior aspect of the right leg that was treated successfully with local application of Madhu and Neem (Azadirachata indica) bark decoction.

Madhu(蜂蜜)的应用是Sushruta描述的Shashthi Upakrama(六十种治疗方式)之一。临床观察显示其治疗慢性创伤的有效性。我们报告一例在右腿前部的大腹赘肉,成功地治疗了局部应用马杜和印度(印楝)树皮煎剂。
{"title":"Role of honey (Madhu) in the management of wounds (Dushta Vrana).","authors":"Tukaram S Dudhamal,&nbsp;S K Gupta,&nbsp;C Bhuyan","doi":"10.4103/0974-7788.76793","DOIUrl":"https://doi.org/10.4103/0974-7788.76793","url":null,"abstract":"<p><p>Application of Madhu (honey) is one among the Shashthi Upakrama (sixty treatment modalities) described by Sushruta. Clinical observation has shown its effectiveness in treatment of Dushta Vrana (chronic wounds). We report a case of Dushta Vrana on the anterior aspect of the right leg that was treated successfully with local application of Madhu and Neem (Azadirachata indica) bark decoction.</p>","PeriodicalId":88901,"journal":{"name":"International journal of Ayurveda research","volume":"1 4","pages":"271-3"},"PeriodicalIF":0.0,"publicationDate":"2010-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4103/0974-7788.76793","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29783388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 17
Antidiabetic activity of Pongamia pinnata leaf extracts in alloxan-induced diabetic rats. 桄榔子叶提取物对四氧嘧啶诱导的糖尿病大鼠的抗糖尿病活性。
Pub Date : 2010-10-01 DOI: 10.4103/0974-7788.76780
Mukesh S Sikarwar, M B Patil

The antidiabetic activity of Pongamia pinnata ( Family: Leguminosae) leaf extracts was investigated in alloxan-induced diabetic albino rats. A comparison was made between the action of different extracts of P. pinnata and a known antidiabetic drug glibenclamide (600 μg/kg b. wt.). An oral glucose tolerance test (OGTT) was also performed in experimental diabetic rats. The petroleum ether, chloroform, alcohol and aqueous extracts of P. pinnata were obtained by simple maceration method and were subjected to standardization using pharmacognostical and phytochemical screening methods. Dose selection was made on the basis of acute oral toxicity study (50-5000 mg/kg b. w.) as per OECD guidelines. P. pinnata ethanolic extract (PPEE) and aqueous extract (PPAE) showed significant (P < 0.001) antidiabetic activity. In alloxan-induced model, blood glucose levels of these extracts on 7th day of the study were 155.83 ± 11.211mg/dl (PPEE) and 132.00 ± 4.955mg/dl (PPAE) in comparison of diabetic control (413.50 ± 4.752mg/dl) and chloroform extract (210.83 ± 14.912mg/dl). In glucose loaded rats, PPEE exhibited glucose level of 164.50 ± 6.350mg/dl after 30 min and 156.50 ± 4.089mg/dl after 90 min, whereas the levels in PPAE treated animals were 176 ± 3.724mg/dl after 30 min and 110.33 ± 6.687mg/dl after 90 min. These extracts also prevented body weight loss in diabetic rats. The drug has the potential to act as an antidiabetic drug.

研究了桄榔子叶提取物对四氧嘧啶诱导的糖尿病白化大鼠的抗糖尿病作用。比较了桄榔子不同提取物与已知抗糖尿病药物格列本脲(600 μg/kg b. wt.)的作用。同时对实验性糖尿病大鼠进行口服糖耐量试验(OGTT)。采用简单浸渍法得到石首菜的石油醚、氯仿、醇和水提物,并采用生药学和植物化学筛选方法进行标准化。剂量选择是根据急性口服毒性研究(50- 5000mg /kg体重)根据经合组织指南进行的。桄榔子醇提物(PPEE)和水提物(PPAE)的抗糖尿病活性显著(P < 0.001)。在四氧嘧啶诱导模型中,与糖尿病对照组(413.50±4.752mg/dl)和氯仿提取物(210.83±14.912mg/dl)相比,四氧嘧啶诱导模型第7天的血糖水平分别为155.83±11.211mg/dl (PPEE)和132.00±4.955mg/dl (PPAE)。在葡萄糖负荷大鼠中,PPEE在30分钟和90分钟后的血糖水平分别为164.50±6.350mg/dl和156.50±4.089mg/dl,而PPAE处理的动物在30分钟和90分钟后的血糖水平分别为176±3.724mg/dl和110.33±6.687mg/dl。这些提取物还可以防止糖尿病大鼠的体重减轻。这种药物有可能成为一种抗糖尿病药物。
{"title":"Antidiabetic activity of Pongamia pinnata leaf extracts in alloxan-induced diabetic rats.","authors":"Mukesh S Sikarwar,&nbsp;M B Patil","doi":"10.4103/0974-7788.76780","DOIUrl":"https://doi.org/10.4103/0974-7788.76780","url":null,"abstract":"<p><p>The antidiabetic activity of Pongamia pinnata ( Family: Leguminosae) leaf extracts was investigated in alloxan-induced diabetic albino rats. A comparison was made between the action of different extracts of P. pinnata and a known antidiabetic drug glibenclamide (600 μg/kg b. wt.). An oral glucose tolerance test (OGTT) was also performed in experimental diabetic rats. The petroleum ether, chloroform, alcohol and aqueous extracts of P. pinnata were obtained by simple maceration method and were subjected to standardization using pharmacognostical and phytochemical screening methods. Dose selection was made on the basis of acute oral toxicity study (50-5000 mg/kg b. w.) as per OECD guidelines. P. pinnata ethanolic extract (PPEE) and aqueous extract (PPAE) showed significant (P < 0.001) antidiabetic activity. In alloxan-induced model, blood glucose levels of these extracts on 7th day of the study were 155.83 ± 11.211mg/dl (PPEE) and 132.00 ± 4.955mg/dl (PPAE) in comparison of diabetic control (413.50 ± 4.752mg/dl) and chloroform extract (210.83 ± 14.912mg/dl). In glucose loaded rats, PPEE exhibited glucose level of 164.50 ± 6.350mg/dl after 30 min and 156.50 ± 4.089mg/dl after 90 min, whereas the levels in PPAE treated animals were 176 ± 3.724mg/dl after 30 min and 110.33 ± 6.687mg/dl after 90 min. These extracts also prevented body weight loss in diabetic rats. The drug has the potential to act as an antidiabetic drug.</p>","PeriodicalId":88901,"journal":{"name":"International journal of Ayurveda research","volume":"1 4","pages":"199-204"},"PeriodicalIF":0.0,"publicationDate":"2010-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4103/0974-7788.76780","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29784558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 65
Effect of tulsi (Ocimum Sanctum Linn.) on sperm count and reproductive hormones in male albino rabbits. 菟丝子对雄性白化兔精子数和生殖激素的影响。
Pub Date : 2010-10-01 DOI: 10.4103/0974-7788.76782
Jyoti Sethi, Mridul Yadav, Sushma Sood, Kiran Dahiya, Veena Singh

Fresh leaves of Ocimum Sanctum (OS) were used to study its effect on male reproductive function (sperm count and reproductive hormones) in male albino rabbits. Animals in the test group received supplementation of 2 g of fresh leaves of OS per rabbit for 30 days, while the control group was maintained on normal diet for the same duration. Sperm count and hormonal estimation [testosterone, follicle stimulating hormone (FSH), and luteinizing hormone (LH)] were done in serum samples of both groups and compared. A significant decrease was noted in the sperm count in test group rabbits. Serum testosterone levels showed marked increase while FSH and LH levels were significantly reduced in OS-treated rabbits. The results suggest the potential use of OS as an effective male contraceptive agent.

本研究采用鲜叶茴香(Ocimum Sanctum, OS)对雄性白化兔雄性生殖功能(精子数和生殖激素)的影响。试验组每只兔补充鲜叶2 g,饲喂30 d,对照组饲喂正常饲料30 d。在两组血清样本中进行精子计数和激素评估[睾酮,促卵泡激素(FSH),黄体生成素(LH)]并进行比较。实验组家兔精子数量明显减少。os处理家兔血清睾酮水平显著升高,FSH和LH水平显著降低。本研究结果提示OS有可能作为一种有效的男性避孕药。
{"title":"Effect of tulsi (Ocimum Sanctum Linn.) on sperm count and reproductive hormones in male albino rabbits.","authors":"Jyoti Sethi,&nbsp;Mridul Yadav,&nbsp;Sushma Sood,&nbsp;Kiran Dahiya,&nbsp;Veena Singh","doi":"10.4103/0974-7788.76782","DOIUrl":"https://doi.org/10.4103/0974-7788.76782","url":null,"abstract":"<p><p>Fresh leaves of Ocimum Sanctum (OS) were used to study its effect on male reproductive function (sperm count and reproductive hormones) in male albino rabbits. Animals in the test group received supplementation of 2 g of fresh leaves of OS per rabbit for 30 days, while the control group was maintained on normal diet for the same duration. Sperm count and hormonal estimation [testosterone, follicle stimulating hormone (FSH), and luteinizing hormone (LH)] were done in serum samples of both groups and compared. A significant decrease was noted in the sperm count in test group rabbits. Serum testosterone levels showed marked increase while FSH and LH levels were significantly reduced in OS-treated rabbits. The results suggest the potential use of OS as an effective male contraceptive agent.</p>","PeriodicalId":88901,"journal":{"name":"International journal of Ayurveda research","volume":"1 4","pages":"208-10"},"PeriodicalIF":0.0,"publicationDate":"2010-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4103/0974-7788.76782","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29784560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 33
Efficacy of Agnikarma over the padakanistakam (little toe) and Katibasti in Gridhrasi: A comparative study. 阿格尼伽玛对小脚趾和小脚趾的疗效比较研究。
Pub Date : 2010-10-01 DOI: 10.4103/0974-7788.76786
Yogitha Bali, R Vijayasarathi, John Ebnezar, Ba Venkatesh

Background and objectives: Gridhrasi (Sciatica) is one of the Vatavyadhi which is caused by aggravated Vata dosha. This disease is characterized by ruja (pain) in the waist, back, thigh, knee and calf regions along the course of sciatic nerve. In spite of the different types of treatment modalities mentioned in ancient and modern medical sciences, they have some or the other shortcomings and drawbacks. Considering all these, the present study was taken up with the objective of evaluating the efficacy of Agnikarma (treatment done with cauterization) over the padakanistakam (little toe) in the management of Gridhrasi. To consider the significance of the method of Agnikarma, the efficacy of Katibasti in the management of Gridhrasi which has been established in the previous work was also studied.

Materials and methods: The study was performed after obtaining Ethics Committee approval and patients' written informed consent. Forty cases presenting with classical features of Gridhrasi (Sciatica) due to lumbar intervertebral disc prolapse were selected. The management of Gridhrasi by Agnikarma and Katibasti was conducted by including the patients in two groups, namely Group A (study group) and Group B (control group). The data were collected and the observations were made before the treatment, on 8(th) day, 15(th) day and on 22(nd) day of the treatment. The data obtained from the results were subjected for statistical analysis and conclusions were drawn.

Results: There was a significant reduction in the parameters, pain (P < 0.01) and straight-leg raising (SLR) test (P < 0.01), of the study group compared to the control group (P < 0.01). Pain was assessed through Numerical Pain Analogue Scale. After the treatment with Agnikarma, the pain was totally relieved in 80% of cases. It was reduced to moderate degree in 20% of cases and in 95% of cases, SLR test became negative. After the treatment with Katibasti, the pain was totally relieved in 50% of cases. It was reduced to moderate degree in 20% and to mild degree in 25% of cases. In 60% of cases, SLR test became negative. However, changes in the radiological findings were not found in both the methods of management. Analysis of overall effect of treatment in the present study reveals that Agnikarma was Both the procedures were conducted in to that of Katibasti.

Conclusions: The management of Gridhrasi by Agnikarma was more efficacious as compared with Katibasti in reducing pain. However, there were no radiological changes produced by both the methods of treatment. Further studies may be conducted by future scholars by taking more samples with more number of sittings.

背景和目的:坐骨神经痛是坐骨神经痛之一,是由坐骨神经痛加重引起的。这种疾病的特点是腰、背、大腿、膝盖和小腿沿着坐骨神经的路线疼痛。尽管古代和现代医学中提到了不同类型的治疗方式,但它们都有一些或其他缺点和缺点。考虑到所有这些,本研究的目的是评估Agnikarma(烧灼治疗)比padakanistakam(小脚趾)治疗Gridhrasi的疗效。为了考虑Agnikarma方法的意义,我们还研究了Katibasti在治疗Gridhrasi方面的有效性,这在之前的工作中已经确立。材料和方法:本研究在获得伦理委员会批准和患者书面知情同意后进行。我们选择了40例典型的腰椎间盘突出引起的坐骨神经痛。Agnikarma和Katibasti对Gridhrasi的治疗分为两组,即A组(研究组)和B组(对照组)。分别于治疗前、治疗第8天、治疗第15天、治疗第22天收集数据并进行观察。对结果得到的数据进行统计分析,得出结论。结果:研究组患者的各项指标、疼痛(P < 0.01)、直腿抬高(SLR)测试(P < 0.01)均较对照组显著降低(P < 0.01)。采用数值疼痛模拟量表评估疼痛。经阿格尼伽玛治疗后,80%的患者疼痛完全缓解。20%的病例降至中度,95%的病例SLR检测呈阴性。经卡提巴斯提治疗后,50%的患者疼痛完全缓解。20%的病例降至中度,25%的病例降至轻度。60%的病例单反检测呈阴性。然而,两种治疗方法均未发现放射学表现的改变。本研究的整体疗效分析表明,Agnikarma的治疗方法与Katibasti的治疗方法相同。结论:阿格尼卡玛治疗Gridhrasi的镇痛效果优于卡提巴斯提。然而,两种治疗方法均未产生放射学改变。未来的学者可能会采取更多的样本和更多的座次进行进一步的研究。
{"title":"Efficacy of Agnikarma over the padakanistakam (little toe) and Katibasti in Gridhrasi: A comparative study.","authors":"Yogitha Bali,&nbsp;R Vijayasarathi,&nbsp;John Ebnezar,&nbsp;Ba Venkatesh","doi":"10.4103/0974-7788.76786","DOIUrl":"https://doi.org/10.4103/0974-7788.76786","url":null,"abstract":"<p><strong>Background and objectives: </strong>Gridhrasi (Sciatica) is one of the Vatavyadhi which is caused by aggravated Vata dosha. This disease is characterized by ruja (pain) in the waist, back, thigh, knee and calf regions along the course of sciatic nerve. In spite of the different types of treatment modalities mentioned in ancient and modern medical sciences, they have some or the other shortcomings and drawbacks. Considering all these, the present study was taken up with the objective of evaluating the efficacy of Agnikarma (treatment done with cauterization) over the padakanistakam (little toe) in the management of Gridhrasi. To consider the significance of the method of Agnikarma, the efficacy of Katibasti in the management of Gridhrasi which has been established in the previous work was also studied.</p><p><strong>Materials and methods: </strong>The study was performed after obtaining Ethics Committee approval and patients' written informed consent. Forty cases presenting with classical features of Gridhrasi (Sciatica) due to lumbar intervertebral disc prolapse were selected. The management of Gridhrasi by Agnikarma and Katibasti was conducted by including the patients in two groups, namely Group A (study group) and Group B (control group). The data were collected and the observations were made before the treatment, on 8(th) day, 15(th) day and on 22(nd) day of the treatment. The data obtained from the results were subjected for statistical analysis and conclusions were drawn.</p><p><strong>Results: </strong>There was a significant reduction in the parameters, pain (P < 0.01) and straight-leg raising (SLR) test (P < 0.01), of the study group compared to the control group (P < 0.01). Pain was assessed through Numerical Pain Analogue Scale. After the treatment with Agnikarma, the pain was totally relieved in 80% of cases. It was reduced to moderate degree in 20% of cases and in 95% of cases, SLR test became negative. After the treatment with Katibasti, the pain was totally relieved in 50% of cases. It was reduced to moderate degree in 20% and to mild degree in 25% of cases. In 60% of cases, SLR test became negative. However, changes in the radiological findings were not found in both the methods of management. Analysis of overall effect of treatment in the present study reveals that Agnikarma was Both the procedures were conducted in to that of Katibasti.</p><p><strong>Conclusions: </strong>The management of Gridhrasi by Agnikarma was more efficacious as compared with Katibasti in reducing pain. However, there were no radiological changes produced by both the methods of treatment. Further studies may be conducted by future scholars by taking more samples with more number of sittings.</p>","PeriodicalId":88901,"journal":{"name":"International journal of Ayurveda research","volume":"1 4","pages":"223-30"},"PeriodicalIF":0.0,"publicationDate":"2010-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4103/0974-7788.76786","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29784564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
A case discussion on eczema. 湿疹1例讨论。
Pub Date : 2010-10-01 DOI: 10.4103/0974-7788.76792
Pallavi Hegde, D T Hemanth, S V Emmi, M P Shilpa, Pradeep S Shindhe, Y M Santosh

Eczema is a form of dermatitis where inflammation of epidermis occurs. The exact cause of eczema is not known. Although it is activated by the immune system and is related to allergic reactions, it is not the same as other allergic reactions. In Ayurveda, the disease is described by the name "Vicharchika." Virechana is the best line of management for skin disorders. Controlling eczema more effectively can make a radical improvement to the patient's quality of life. A case report of 45-year-old male, who presented with complaints of rashes over dorsum of both foot associated with intense itching and burning sensation, oozing wound posterior to lateral malleolus and dorsum of left foot has been presented here.

湿疹是皮炎的一种形式,发生表皮炎症。湿疹的确切病因尚不清楚。虽然它是由免疫系统激活的,与过敏反应有关,但它与其他过敏反应不一样。在阿育吠陀中,这种疾病被称为“Vicharchika”。Virechana是治疗皮肤疾病的最佳药物。更有效地控制湿疹可以从根本上改善患者的生活质量。病例报告45岁男性,谁提出的主诉皮疹在脚背与强烈的瘙痒和烧灼感,渗出伤口后外踝和左脚背在这里已经提出。
{"title":"A case discussion on eczema.","authors":"Pallavi Hegde,&nbsp;D T Hemanth,&nbsp;S V Emmi,&nbsp;M P Shilpa,&nbsp;Pradeep S Shindhe,&nbsp;Y M Santosh","doi":"10.4103/0974-7788.76792","DOIUrl":"https://doi.org/10.4103/0974-7788.76792","url":null,"abstract":"<p><p>Eczema is a form of dermatitis where inflammation of epidermis occurs. The exact cause of eczema is not known. Although it is activated by the immune system and is related to allergic reactions, it is not the same as other allergic reactions. In Ayurveda, the disease is described by the name \"Vicharchika.\" Virechana is the best line of management for skin disorders. Controlling eczema more effectively can make a radical improvement to the patient's quality of life. A case report of 45-year-old male, who presented with complaints of rashes over dorsum of both foot associated with intense itching and burning sensation, oozing wound posterior to lateral malleolus and dorsum of left foot has been presented here.</p>","PeriodicalId":88901,"journal":{"name":"International journal of Ayurveda research","volume":"1 4","pages":"268-70"},"PeriodicalIF":0.0,"publicationDate":"2010-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4103/0974-7788.76792","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29783387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
Understanding survival analysis: Kaplan-Meier estimate. 理解生存分析:Kaplan-Meier估计。
Pub Date : 2010-10-01 DOI: 10.4103/0974-7788.76794
Manish Kumar Goel, Pardeep Khanna, Jugal Kishore

Kaplan-Meier estimate is one of the best options to be used to measure the fraction of subjects living for a certain amount of time after treatment. In clinical trials or community trials, the effect of an intervention is assessed by measuring the number of subjects survived or saved after that intervention over a period of time. The time starting from a defined point to the occurrence of a given event, for example death is called as survival time and the analysis of group data as survival analysis. This can be affected by subjects under study that are uncooperative and refused to be remained in the study or when some of the subjects may not experience the event or death before the end of the study, although they would have experienced or died if observation continued, or we lose touch with them midway in the study. We label these situations as censored observations. The Kaplan-Meier estimate is the simplest way of computing the survival over time in spite of all these difficulties associated with subjects or situations. The survival curve can be created assuming various situations. It involves computing of probabilities of occurrence of event at a certain point of time and multiplying these successive probabilities by any earlier computed probabilities to get the final estimate. This can be calculated for two groups of subjects and also their statistical difference in the survivals. This can be used in Ayurveda research when they are comparing two drugs and looking for survival of subjects.

Kaplan-Meier估计值是衡量治疗后存活一定时间的受试者比例的最佳选择之一。在临床试验或社区试验中,通过测量一段时间内干预后存活或挽救的受试者数量来评估干预的效果。从一个确定的点开始到一个给定事件(例如死亡)发生的时间称为生存时间,对群体数据的分析称为生存分析。这可能会受到研究对象的影响,他们不合作,拒绝留在研究中,或者当一些研究对象可能在研究结束前没有经历事件或死亡,尽管如果继续观察,他们会经历或死亡,或者我们在研究过程中与他们失去联系。我们将这些情况标记为经过审查的观察。卡普兰-迈耶估计是计算随时间推移的存活率的最简单方法,尽管所有这些困难都与受试者或情境有关。生存曲线可以在各种情况下生成。它包括计算事件在某一时间点发生的概率,并将这些连续的概率乘以任何先前计算的概率,以得到最终的估计。这可以计算两组受试者,以及他们在存活率上的统计差异。这可以用于阿育吠陀研究,当他们比较两种药物,寻找生存的对象。
{"title":"Understanding survival analysis: Kaplan-Meier estimate.","authors":"Manish Kumar Goel,&nbsp;Pardeep Khanna,&nbsp;Jugal Kishore","doi":"10.4103/0974-7788.76794","DOIUrl":"https://doi.org/10.4103/0974-7788.76794","url":null,"abstract":"<p><p>Kaplan-Meier estimate is one of the best options to be used to measure the fraction of subjects living for a certain amount of time after treatment. In clinical trials or community trials, the effect of an intervention is assessed by measuring the number of subjects survived or saved after that intervention over a period of time. The time starting from a defined point to the occurrence of a given event, for example death is called as survival time and the analysis of group data as survival analysis. This can be affected by subjects under study that are uncooperative and refused to be remained in the study or when some of the subjects may not experience the event or death before the end of the study, although they would have experienced or died if observation continued, or we lose touch with them midway in the study. We label these situations as censored observations. The Kaplan-Meier estimate is the simplest way of computing the survival over time in spite of all these difficulties associated with subjects or situations. The survival curve can be created assuming various situations. It involves computing of probabilities of occurrence of event at a certain point of time and multiplying these successive probabilities by any earlier computed probabilities to get the final estimate. This can be calculated for two groups of subjects and also their statistical difference in the survivals. This can be used in Ayurveda research when they are comparing two drugs and looking for survival of subjects.</p>","PeriodicalId":88901,"journal":{"name":"International journal of Ayurveda research","volume":"1 4","pages":"274-8"},"PeriodicalIF":0.0,"publicationDate":"2010-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4103/0974-7788.76794","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29783389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 846
Mahayograj guggulu: Heavy metal estimation and safety studies. Mahayograj guggulu:重金属估算和安全性研究
Pub Date : 2010-07-01 DOI: 10.4103/0974-7788.72486
G S Lavekar, B Ravishankar, S Gaidhani, V J Shukla, B K Ashok, M M Padhi

Objective: This study was conducted to estimate the heavy metal profile and determine the safety of Mahayograj guggulu, an Ayurvedic herbo-mineral preparation.

Design: Mahayograj guggulu, manufactured by Shree Baidynath Ayurved Bhawan Pvt. Ltd., Gwalior Road, Jhansi - 284 003 (of batch number-07 and manufacturing date October 2004) was procured from the local market. Heavy metal concentrations were measured using an atomic absorption spectrophotometer. A total of 40 Charles Foster strain albino rats of either sex with an average body weight of 160-250 g were divided into four groups (Groups I, II, III and IV), with 10 animals in each group. Group I served as the control, while Group II, III and IV rats received Mahayograj guggulu at a dose of 54 (dose equivalent to human therapeutic dose), 270 (five-times the dose equivalent to the human therapeutic dose) and 540 (10-times the dose equivalent to human therapeutic dose) mg/kg, p.o. for 120 days. The effect of drug administration was noted on the ponderal, biochemical, hematological and histopathological parameters. In addition, urine examination was also carried out. At the end of the study, only six rats per group were sacrificed as per the IAEC advice.

Results: Mahayograj guggulu was found to be safe at all dose levels tested. No significant behavioral changes were noted in any of the groups studied. The effect on food and water consumption and fecal and urine output remained unaffected in all groups during the study period. No major alterations were observed in hematology, serum biochemistry, necropsy and histopathology at the therapeutically advocated dose level. Heavy metal content measurement indicated levels of 25.8 µg/g for lead, 0.07 µg/g for mercury and 5.19 µg/g for arsenic.

Conclusions: The test drug is well tolerated as no changes of a serious nature could be observed in any of the parameters assessed.

研究目的本研究旨在估算阿育吠陀草本矿物质制剂 Mahayograj guggulu 的重金属含量,并确定其安全性:Mahayograj guggulu由Shree Baidynath Ayurved Bhawan Pvt. Ltd., Gwalior Road, Jhansi - 284 003生产(批号为07,生产日期为2004年10月),从当地市场购买。使用原子吸收分光光度计测量重金属浓度。将平均体重为 160-250 克的 40 只查尔斯-福斯特品系白化大鼠分为四组(I、II、III 和 IV 组),每组 10 只。I 组为对照组,II、III 和 IV 组大鼠分别接受 54(相当于人类治疗剂量)、270(相当于人类治疗剂量的 5 倍)和 540(相当于人类治疗剂量的 10 倍)毫克/千克的 Mahayograj guggulu 剂量,口服 120 天。研究人员注意到了给药对钙化、生化、血液学和组织病理学参数的影响。此外,还进行了尿液检查。研究结束时,根据 IAEC 的建议,每组仅有六只大鼠被处死:结果:在所有测试剂量水平下,Mahayograj guggulu都是安全的。所研究的各组大鼠均未出现明显的行为变化。在研究期间,所有研究组的食物和水消耗量以及粪便和尿液排出量均未受到影响。在治疗剂量水平下,血液学、血清生化学、尸体解剖和组织病理学均未发现重大变化。重金属含量测量结果显示,铅含量为 25.8 微克/克,汞含量为 0.07 微克/克,砷含量为 5.19 微克/克:结论:试验药物的耐受性良好,在评估的任何参数中均未观察到严重的性质变化。
{"title":"Mahayograj guggulu: Heavy metal estimation and safety studies.","authors":"G S Lavekar, B Ravishankar, S Gaidhani, V J Shukla, B K Ashok, M M Padhi","doi":"10.4103/0974-7788.72486","DOIUrl":"10.4103/0974-7788.72486","url":null,"abstract":"<p><strong>Objective: </strong>This study was conducted to estimate the heavy metal profile and determine the safety of Mahayograj guggulu, an Ayurvedic herbo-mineral preparation.</p><p><strong>Design: </strong>Mahayograj guggulu, manufactured by Shree Baidynath Ayurved Bhawan Pvt. Ltd., Gwalior Road, Jhansi - 284 003 (of batch number-07 and manufacturing date October 2004) was procured from the local market. Heavy metal concentrations were measured using an atomic absorption spectrophotometer. A total of 40 Charles Foster strain albino rats of either sex with an average body weight of 160-250 g were divided into four groups (Groups I, II, III and IV), with 10 animals in each group. Group I served as the control, while Group II, III and IV rats received Mahayograj guggulu at a dose of 54 (dose equivalent to human therapeutic dose), 270 (five-times the dose equivalent to the human therapeutic dose) and 540 (10-times the dose equivalent to human therapeutic dose) mg/kg, p.o. for 120 days. The effect of drug administration was noted on the ponderal, biochemical, hematological and histopathological parameters. In addition, urine examination was also carried out. At the end of the study, only six rats per group were sacrificed as per the IAEC advice.</p><p><strong>Results: </strong>Mahayograj guggulu was found to be safe at all dose levels tested. No significant behavioral changes were noted in any of the groups studied. The effect on food and water consumption and fecal and urine output remained unaffected in all groups during the study period. No major alterations were observed in hematology, serum biochemistry, necropsy and histopathology at the therapeutically advocated dose level. Heavy metal content measurement indicated levels of 25.8 µg/g for lead, 0.07 µg/g for mercury and 5.19 µg/g for arsenic.</p><p><strong>Conclusions: </strong>The test drug is well tolerated as no changes of a serious nature could be observed in any of the parameters assessed.</p>","PeriodicalId":88901,"journal":{"name":"International journal of Ayurveda research","volume":"1 3","pages":"150-8"},"PeriodicalIF":0.0,"publicationDate":"2010-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996572/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29546008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study of the synergistic anti-inflammatory activity of Solanum xanthocarpum Schrad and Wendl and Cassia fistula Linn. 黄果茄与决明子协同抗炎作用的研究。
Pub Date : 2010-07-01 DOI: 10.4103/0974-7788.72489
Shraddha Anwikar, Milind Bhitre

Introduction: Nonsteroidal and steroidal drugs are generally used as a part of drug therapy in inflammation. However, these drugs have severe side-effects like nausea and vomiting. Therefore, there is a need to identify anti-inflammatory compounds that will be effective with a better safety profile. Solanum xanthocarpum Schrad and Wendl and Cassia fistula Linn has many therapeutic uses mentioned in Ayurveda and therefore we aimed to study its anti-inflammatory activity both alone and in combination.

Materials and methods: The water extract of dried fruits of Solanum xanthocarpum Schrad and Wendl and dried pulp of Cassia fistula Linn was prepared. The anti-inflammatory activity of these extracts was investigated using the carragenan-induced paw edema model in rats individually and in two different combinations. ED50 of both the extracts singly and in combination were calculated by dose-response curves, and this information was then plotted on the isobologram. The interaction index of the extracts was also investigated to determine whether both the extracts in combination show synergistic or antagonistic or additive effects.

Results: It was observed that extracts of dried fruits of Solanum xanthocarpum showed more anti-inflammatory activity than dried fruits of Cassia fistula Linn. Both the extracts showed maximum anti-inflammatory activity at 500 mg/kg dose. Among the different dose combinations of both the extracts, the 1:1 combination at the 500 mg/kg dose showed maximum percentage inhibition of 75%, which was comparable with the positive control, diclofenac sodium, which showed 81% inhibition.

Conclusion: As revealed by the isobolograms, both the combinations fell below the additivity line, which indicates synergistic interactions between Solanum xanthocarpum and Cassia fistula extracts. Interaction indices of both combinations were observed to be <1, which re-demonstrated the synergistic effects of the combination.

简介:非甾体类和甾体类药物通常作为炎症药物治疗的一部分。然而,这些药物有严重的副作用,如恶心和呕吐。因此,有必要确定抗炎化合物,将有效和更好的安全性。黄果茄和决明子在阿育吠陀中有许多治疗用途,因此我们旨在研究其单独和联合使用的抗炎活性。材料与方法:制备了黄果茄、黄果茄干果水提物和决明子干浆。采用角叉菜胶诱导的大鼠足跖水肿模型和两种不同组合研究了这些提取物的抗炎活性。分别用剂量-响应曲线计算两种提取物单独和联合使用的ED50,并将此信息绘制在等温图上。还研究了两种提取物的相互作用指数,以确定两种提取物联合使用是否具有协同或拮抗或加性作用。结果:黄果茄干果提取物的抗炎活性高于决明子干果提取物。两种提取物在500 mg/kg剂量下抗炎活性最大。在两种提取物的不同剂量组合中,500 mg/kg剂量下1:1组合的最大抑制率为75%,与阳性对照双氯芬酸钠的抑制率为81%相当。结论:等线形图显示,两种组合均在加和线以下,表明黄果茄与决明子提取物之间存在协同作用。两个组合的交互作用指数为
{"title":"Study of the synergistic anti-inflammatory activity of Solanum xanthocarpum Schrad and Wendl and Cassia fistula Linn.","authors":"Shraddha Anwikar,&nbsp;Milind Bhitre","doi":"10.4103/0974-7788.72489","DOIUrl":"https://doi.org/10.4103/0974-7788.72489","url":null,"abstract":"<p><strong>Introduction: </strong>Nonsteroidal and steroidal drugs are generally used as a part of drug therapy in inflammation. However, these drugs have severe side-effects like nausea and vomiting. Therefore, there is a need to identify anti-inflammatory compounds that will be effective with a better safety profile. Solanum xanthocarpum Schrad and Wendl and Cassia fistula Linn has many therapeutic uses mentioned in Ayurveda and therefore we aimed to study its anti-inflammatory activity both alone and in combination.</p><p><strong>Materials and methods: </strong>The water extract of dried fruits of Solanum xanthocarpum Schrad and Wendl and dried pulp of Cassia fistula Linn was prepared. The anti-inflammatory activity of these extracts was investigated using the carragenan-induced paw edema model in rats individually and in two different combinations. ED50 of both the extracts singly and in combination were calculated by dose-response curves, and this information was then plotted on the isobologram. The interaction index of the extracts was also investigated to determine whether both the extracts in combination show synergistic or antagonistic or additive effects.</p><p><strong>Results: </strong>It was observed that extracts of dried fruits of Solanum xanthocarpum showed more anti-inflammatory activity than dried fruits of Cassia fistula Linn. Both the extracts showed maximum anti-inflammatory activity at 500 mg/kg dose. Among the different dose combinations of both the extracts, the 1:1 combination at the 500 mg/kg dose showed maximum percentage inhibition of 75%, which was comparable with the positive control, diclofenac sodium, which showed 81% inhibition.</p><p><strong>Conclusion: </strong>As revealed by the isobolograms, both the combinations fell below the additivity line, which indicates synergistic interactions between Solanum xanthocarpum and Cassia fistula extracts. Interaction indices of both combinations were observed to be <1, which re-demonstrated the synergistic effects of the combination.</p>","PeriodicalId":88901,"journal":{"name":"International journal of Ayurveda research","volume":"1 3","pages":"167-71"},"PeriodicalIF":0.0,"publicationDate":"2010-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4103/0974-7788.72489","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29546460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 53
Overdose effect of aconite containing Ayurvedic Medicine ('Mahashankha Vati'). 含有阿育吠陀药物(Mahashankha Vati)的乌头的过量效果。
Pub Date : 2010-07-01 DOI: 10.4103/0974-7788.72493
Ashok Kumar Panda, Saroj Kumar Debnath

There are chances that the use of larger than recommended dose of Ayurvedic medicines containing aconite can produce drug reactions. Vatsanabha (Aconitum ferox Wall.) is a very well-known ingredient of Ayurvedic formulations and is prescribed as an antipyretic, analgesic, anti-rheumatic, appetizer and digestive. The recommended dose of purified Vatsanabha (A. ferox Wall.) root is 15 mg. We present a case of hypotension and bradycardia due to aconite poisoning caused by overdosing of an Ayurvedic medicine (Mahashankha Vati), which was primarily managed by Ayurvedic treatment.

有可能使用大于推荐剂量的含有乌头的阿育吠陀药物会产生药物反应。Vatsanabha(乌头)是一种非常著名的阿育吠陀配方成分,被规定为解热,镇痛,抗风湿,开胃和消化。推荐的纯化缬草(A. ferox Wall.)根剂量为15毫克。我们提出了一例低血压和心动过缓由于乌头中毒引起的过量服用阿育吠陀药物(Mahashankha Vati),这是主要由阿育吠陀治疗管理。
{"title":"Overdose effect of aconite containing Ayurvedic Medicine ('Mahashankha Vati').","authors":"Ashok Kumar Panda,&nbsp;Saroj Kumar Debnath","doi":"10.4103/0974-7788.72493","DOIUrl":"https://doi.org/10.4103/0974-7788.72493","url":null,"abstract":"<p><p>There are chances that the use of larger than recommended dose of Ayurvedic medicines containing aconite can produce drug reactions. Vatsanabha (Aconitum ferox Wall.) is a very well-known ingredient of Ayurvedic formulations and is prescribed as an antipyretic, analgesic, anti-rheumatic, appetizer and digestive. The recommended dose of purified Vatsanabha (A. ferox Wall.) root is 15 mg. We present a case of hypotension and bradycardia due to aconite poisoning caused by overdosing of an Ayurvedic medicine (Mahashankha Vati), which was primarily managed by Ayurvedic treatment.</p>","PeriodicalId":88901,"journal":{"name":"International journal of Ayurveda research","volume":"1 3","pages":"183-6"},"PeriodicalIF":0.0,"publicationDate":"2010-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4103/0974-7788.72493","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29546464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 18
Exploring larger evidence base for contemporary Ayurveda. 探索当代阿育吠陀的更大证据基础。
Pub Date : 2010-07-01 DOI: 10.4103/0974-7788.72497
Sanjeev Rastogi
Sir, I read the recent publication on ligation by Singh et al.[1] with great interest. The authors concluded that “Kshar Sutra ligation is a useful form of treatment for Grades II and III internal hemorrhoids.”[1] I agree that this report might imply some clinical usefulness of Kshar Sutra ligation. The thread that is used in Kshar Sutra therapy is confirmed for active compositions in ethnopharmacology.[2] However, there are some points to be further discussed. First, there are a few subjects studied, which might limit the usefulness of the results. The clarification on statistical acceptability is needed. Second, it is interesting to know the comparative cost effectiveness between both ligation techniques. Third, the comparison on the operative time and attempt as well as acute and long-term complications rate should also be done. To fulfill the present study, these information are required.
{"title":"Exploring larger evidence base for contemporary Ayurveda.","authors":"Sanjeev Rastogi","doi":"10.4103/0974-7788.72497","DOIUrl":"https://doi.org/10.4103/0974-7788.72497","url":null,"abstract":"Sir, I read the recent publication on ligation by Singh et al.[1] with great interest. The authors concluded that “Kshar Sutra ligation is a useful form of treatment for Grades II and III internal hemorrhoids.”[1] I agree that this report might imply some clinical usefulness of Kshar Sutra ligation. The thread that is used in Kshar Sutra therapy is confirmed for active compositions in ethnopharmacology.[2] However, there are some points to be further discussed. First, there are a few subjects studied, which might limit the usefulness of the results. The clarification on statistical acceptability is needed. Second, it is interesting to know the comparative cost effectiveness between both ligation techniques. Third, the comparison on the operative time and attempt as well as acute and long-term complications rate should also be done. To fulfill the present study, these information are required.","PeriodicalId":88901,"journal":{"name":"International journal of Ayurveda research","volume":"1 3","pages":"195-6"},"PeriodicalIF":0.0,"publicationDate":"2010-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4103/0974-7788.72497","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29546467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
International journal of Ayurveda research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1